Parexel Akan Diakuisisi oleh EQT Private Equity dan Goldman Sachs Asset Management
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON dan DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, sebuah organisasi riset klinis global (CRO/clinical research organization) terkemuka yang berfokus pada pengembangan dan...
Parexel adquirida por EQT Private Equity y Goldman Sachs Asset Management
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON y DURHAM, Carolina del Norte, July 06, 2021 (GLOBE NEWSWIRE) -- Parexel, una organización líder mundial de investigación clínica (CRO) centrada en el desarrollo y entrega de nuevas terapias...
パレクセルをEQTプライベート･エクイティとゴールドマン･サックス･アセット･マネジメントが買収
July 06, 2021 14:52 ET
|
Parexel International LLC
ボストンおよびノースカロライナ州ダーラム発, July 07, 2021 (GLOBE NEWSWIRE) -- 患者の健康を増進するために革新的な治療薬の開発･提供に注力する国際的な大手医薬品開発業務受託機関 (CRO) であるパレクセル (Parexel) は本日、最終的な合併契約締結を発表した。この契約の下、同社は (先にパレクセル株式を買収した) パンプローナ･キャピタル･マネジメント...
Parexel 被 EQT Private Equity 及 Goldman Sachs Asset Management 收購
July 06, 2021 14:52 ET
|
Parexel International LLC
波士頓及北卡羅來納州達勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- Parexel 是一家領先的全球臨床研究組織，專注開發和提供創新的新療法以促進患者健康，今天宣佈執行最終合併協議，公司將被 EQT IX 基金（「EQT Private Equity」）以及 Pamplona Capital Management LP 旗下的 Goldman Sachs...
Parexel即将由EQT Private Equity和Goldman Sachs Asset Management收购
July 06, 2021 14:52 ET
|
Parexel International LLC
波士顿和北卡罗来纳州达勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- 专注于开发和提供创新疗法以促进患者健康的全球领先临床研究机构（CRO）Parexel今天宣布了一项最终合并协议的执行。根据该协议，EQT IX基金（“EQT Private Equity”）和Goldman Sachs Asset Management旗下私募股权业务部门（“Goldman...
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
July 02, 2021 10:33 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Introduces Discussions on Diversity Research to Promote Diversity in Clinical Trials
May 20, 2021 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth...
Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report
May 13, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report
May 04, 2021 09:00 ET
|
Parexel International LLC
BOSTON and Durham, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
February 04, 2021 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C. and FT. MYERS, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve...